Actively Recruiting
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Led by Fudan University · Updated on 2023-11-24
100
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy of thalidomide on improving the quality of life for metastatic pancreatic cancer patients receiving gemcitabine and nab-paclitaxel chemotherapy.
CONDITIONS
Official Title
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to understand and sign written informed consent
- Age between 18 and 80 years
- ECOG performance status 0-2
- Histologically or cytologically confirmed metastatic pancreatic adenocarcinoma
- Adequate organ function based on lab tests
- At least one measurable lesion per RECIST criteria
- Expected survival of 3 months or more
- Women of childbearing potential and men agree to use effective contraception during the study
You will not qualify if you...
- Prior anti-tumor therapy received
- Diagnosis of pancreatic cancer other than adenocarcinoma
- Inflammation of digestive tract (e.g., pancreatitis, cholecystitis, cholangitis)
- Pregnant or nursing women
- Severe or uncontrolled diseases affecting compliance or safety (e.g., active infections, uncontrolled diabetes, severe heart failure, recent heart attack, unstable arrhythmia or angina, recent stroke)
- History of allergic reactions to gemcitabine, nab-paclitaxel, or similar agents
- Other serious illnesses that may affect treatment safety
- Unwillingness or inability to comply with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
Y
Ying Yang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here